At 11% CAGR, Global Peptide Therapeutics Market Size is Expected to Reach USD 74 Bn by 2028 Says Zion Market Research - Industry Trends, Share, Value, Analysis & Forecast Report
10 Jun 2022
Acquisition
NEW YORK, June 10, 2022 /PRNewswire/ -- As per the Zion Market Research study,
The global peptide therapeutics market was valued at $35B in 2021 and is projected to grow at 11% CAGR during the forecast period & reach over $74B by 2028. The report analyzes the peptide therapeutics market's drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the global peptide therapeutics market.
Key Industry Insights & Findings of the Peptide Therapeutics Market Reports:
As per the analysis shared by our research analyst, the Peptide Therapeutics Market is expected to grow annually at a CAGR of around
11 % (2022-2028).
Through the primary research, it was established that the Cognitive and Memory Enhancer Drugs Market was valued at approximately
USD
35 Billion in 2021 and is projected to reach roughly
USD
74 Billion by 2028.
North America region is the hub of key pharmaceutical players, high technology, R&D investment capacity, and world-class cancer treatment facilities, making it a heavily contributing region in the global market.
Europe is expected to show steady growth in the global market because of its advanced healthcare infrastructure and growing awareness related to peptide therapeutics.
Africa & Latin America are expected to grow slowly owing to a lack of information on peptide therapeutics along with an absence of necessary healthcare infrastructure, resources, and treatment facilities.
Zion Market Research published the latest report titled
"
Peptide Therapeutics Market By Route Of Administration (Parenteral, Oral, And Others), By Type (Innovative And Generic), By Type Of Manufacturers (In-House And Outsourced), By Type Of Molecule (Vasopressin, Somatostatin, Calcitonin, Immunopeptide, Natriuretic, And Others), By Technology (Liquid Phase, Solid Phase, And Hybrid Phase), By Application (Cancer, Cardiovascular Disease, Metabolic Disease, Respiratory Disease, Infectious Disease, And Others), And By Region: Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2022 – 2028
" into their research database.
Peptide Therapeutics Market: Overview
Peptide therapeutics are naturally created disease-treating small chain amino acids known as peptides. They assist humans in hormone creation and are excellent at protecting from infections. Since peptide therapeutics are naturally created by the body, they do not have any side effects and are easily accepted by the body during medical treatments.
Peptide therapeutics are century-old but were only known for their healing abilities. However, with technological advancements and extensive R&D, it was discovered that peptide therapeutics have extreme potential in treating severe diseases with great efficiency.
The global peptide therapeutics market has a substantial presence in the field of acute respiratory disorders, endocrinology, oncology, metabolism disorders, diabetes, dermatology, gastroenterology, and sexual dysfunction. They are also used to treat cardiovascular diseases and bone diseases.
Get a Free Sample Report with All Related Graphs & Charts (with COVID 19 Impact Analysis):
https://www.zionmarketresearch.com/sample/peptide-therapeutics-market
Our Free Sample Report Includes:
2022 Updated Report Introduction, Overview, and In-depth industry analysis
COVID-19 Pandemic Outbreak Impact Analysis Included
199 + Pages Research Report (Inclusion of Updated Research)
Provide Chapter-wise guidance on Request
2022 Updated Regional Analysis with Graphical Representation of Size, Share & Trends
Includes an Updated List of tables & figures
Updated Report Includes Top Market Players with their Business Strategy, Sales Volume, and Revenue Analysis
Zion Market Research methodology
Peptide Therapeutics Market: Growth Drivers
Increase in cancer patients and respiratory disorders to propel the global market growth.
The growing number of patients suffering from cancer and its after-effects is a leading global market driver. The most prevalent treatment for cancer involves chemotherapy and radiation which leave long-lasting impacts on the patients giving rise to requirements for substitutes like peptide therapeutics. This is expected to move the global peptide therapeutics market forward. Other chronic diseases like diabetes or cardiovascular diseases are also contributing to the global market growth.
Rising demand for drugs that have minimal to no side effects like peptide therapeutics is attributed to becoming the global market driver during the forecast period.
Exhaustive R&D on diseases that might raise global concerns and which can be treated by peptide therapeutics in the future is anticipated to drive the global market.
Peptide Therapeutics Market: Restraints
Unstable nature of peptide therapeutics likely to hamper market growth.
Peptide therapeutics are extremely unstable rendering them difficult to be used. They can aggregate quickly resulting in damage to healthy cells. The volatility of peptide proteins is projected to act as a restraining factor for the global market growth.
In most cases, peptide therapeutics cannot be administered orally. The invasive techniques used for the intake of peptide-based drugs may cause reluctance amongst certain sections of the global population and are anticipated to restrain the global market during the forecast period.
Peptide therapeutics lack deep membrane permeability thus reducing the overall efficiency of the products, which is further anticipated to restrict the global market growth.
Peptide therapeutics tend to oxidize under improper care. The easy oxidization of peptide proteins increases task tediousness and is expected to hamper the global market.
Directly Purchase a Copy of the Report at
https://www.zionmarketresearch.com/buynow/su/peptide-therapeutics-market
Global Peptide Therapeutics Market: Opportunities
Advent of multi-functional peptide therapeutics to bring growth prospects in the coming period.
The global peptide therapeutics market has immense opportunities given the innumerable benefits of peptide-based drugs. The creation of multi-functional peptide therapeutics with an even wider array of use is anticipated to provide excellent growth opportunities in the global market.
Increased innovation in alternate delivery modes of peptide therapeutics is expected to open multiple opportunities for the global market during the forecast period.
Even though the presence of peptide therapeutics in the human body has been for more than a century, their discovery is a recent event. With every passing day more & more peptide therapeutics are added to the global market. As of 2022, there are more than 200 peptide therapeutics in the global market and with ongoing R&D, more are expected to be added soon.
This is anticipated to open multiple growth opportunities in the global market.
Global Peptide Therapeutics Market: Challenges
Shift towards proteomics, high cost of peptide therapeutics along with quick expiration of patents to challenge the global market growth.
The global market is expected to move toward the study of proteins also called proteomics to create substitutes for peptide-based drugs which is anticipated to challenge the global market growth during the forecast period.
The development of peptide therapeutics is an expensive affair and the high cost of production & maintenance is anticipated to create challenging situations in the global market.
The creation of novel drugs requires approval from regulatory bodies and the approval process is extremely stringent which is anticipated to become a challenging factor in the global market.
A considerable number of patents for peptide therapeutics expire quickly which results in heavy losses to drug manufacturers and is anticipated to oppose the global market growth during the forecast period.
Global Peptide Therapeutics Market: Segmentation
The global peptide therapeutics market is segmented by route of administration, type, type of manufacturers, type of molecule, technology, application, and region
Based on the route of administration, the global market is segmented into parenteral, oral, and others. Currently, the global market is led by the parenteral mode, however, the global market is anticipated to be led by the oral mode of administration, during the forecast period.
Based on the type of manufacturers, the global market is segmented as in-house and outsourced. In-house manufacturing shares the highest market share and the same trend is anticipated during the forecast period, because of stringent rules laid down by regulatory bodies.
Based on technology, the global market is segmented into liquid phase, solid phase, and hybrid phase. The largest global market share was held by the liquid phase and is expected to continue with the same trend during the forecast period.
Get More Insight before Buying at: https://www.zionmarketresearch.com/inquiry/peptide-therapeutics-market
List of Key Players in Peptide Therapeutics Market:
Sanofi S.A
Amazen Inc.
Ipsen S.A
Eli Lilly and Company
Key questions answered in this report:
What are the growth rate forecast and market size for Peptide Therapeutics Market?
What are the key driving factors propelling the Peptide Therapeutics Market forward?
What are the most important companies in the Peptide Therapeutics Market Industry?
What segments does the Peptide Therapeutics Market cover?
How can I receive a free copy of the Peptide Therapeutics Market sample report and company profiles?
Free Brochure: https://www.zionmarketresearch.com/requestbrochure/peptide-therapeutics-market
Recent Developments:
August 2019 witnessed the merger of Neoleukin Inc. and Aquinox Pharmaceuticals to invest in peptide therapeutics which are designed computationally. The firms intend to produce peptide-based drugs for diseases that currently do not have peptide therapeutics available for treatment.
In June 2019, a collaboration between Gubra and Boehringer Ingelheim International was announced. The collaboration is intended to pave a way for newer peptide therapeutics drugs that will help in treating diabetes.
Regional Dominance:
North America to lead the global market during the forthcoming period.
The global peptide therapeutics market is anticipated to be led by North America. This region is the hub of key pharmaceutical players, high technology, R&D investment capacity, and world-class cancer treatment facilities, making it a heavily contributing region in the global market.
Europe is expected to show steady growth in the global market because of its advanced healthcare infrastructure and growing awareness related to peptide therapeutics.
Asia-Pacific & the Middle East witnessed a rise in the global market because of Covid-19. Rising cancer, diabetes, and acute respiratory disorders along with increased healthcare investments are anticipated to assist the global market growth.
Africa & Latin America are expected to grow slowly owing to a lack of information on peptide therapeutics along with an absence of necessary healthcare infrastructure, resources, and treatment facilities.
Global Peptide Therapeutics Market is segmented as follows:
Peptide Therapeutics Market: By Route of Administration Outlook (2022-2028)
Oral
Others
Peptide Therapeutics Market: By Type Outlook (2022-2028)
Innovative
Peptide Therapeutics Market: By Type of Manufacturers Outlook (2022-2028)
In-house
Outsourced
Peptide Therapeutics Market: By Type of Molecule Outlook (2022-2028)
Vasopressin
Somatostatin
Calcitonin
Immunopeptide
Natriuretic
Others
Peptide Therapeutics Market: By Technology Outlook (2022-2028)
Liquid phase
Hybrid phase
Peptide Therapeutics Market: By Application Outlook (2022-2028)
Cancer
Others
Peptide Therapeutics Market: By Region Outlook (2022-2028)
North America
The U.S.
Canada
Europe
France
The UK
Spain
Germany
Italy
Rest of Europe
China
Japan
India
South Korea
Southeast Asia
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
GCC
South Africa
Rest of Middle East & Africa
Browse Other Related Research Reports from Zion Market Research
Genomics Personalized Health Market - Global Industry Analysis
: The global Genomics Personalized Health market accounted for USD 4,789.2 Million in 2020 and is expected to reach USD 6,649.2 Million by 2028, growing at a CAGR of 4.4% from 2021 to 2028.
Medical Supply Delivery Service Market - Global Industry Analysis
: The global Medical Supply Delivery Service Market accrued earnings worth approximately 49.1 (USD Billion) in 2020 and is predicted to gain revenue of about 104.2 (USD Billion) by 2028, is set to record a CAGR of nearly 10.2% over the period from 2021 to 2028.
Healthcare Video Conferencing Solutions Market - Global Industry Analysis
: The global Healthcare Video Conferencing Solutions Market accrued earnings worth approximately 76.1 (USD Million) in 2020 and is predicted to gain revenue of about 115.2 (USD Million) by 2028, is set to record a CAGR of nearly 4.8% over the period from 2021 to 2028.
Browse through Zion Market Research's coverage of the
Global
Healthcare
Industry
Follow Us on: LinkedIn | Twitter | Facebook
About Us
Zion Market Research is an obligated company. We create futuristic, cutting edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client's needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us
.
Contact Us:
Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651
Email: [email protected]
Website: https://www.zionmarketresearch.com/
Blog - https://zmrblog.com/
SOURCE Zion Market Research
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
-Drugs
-Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.